You are here: Industry Insights > Azelastine

News List

FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use drugs
June 18, 2021
Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine HCI .15%) as an over-the-counter (OTC) product for the temporary relief of nasal congestion, runny nose, sneezing and itchy nose due.
FDA Approves a Nasal Antihistamine for Nonprescription Use fda.gov
June 18, 2021
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
CEBINA Reports Positive Findings on Azelastine Potency for COVID-19 americanpharmaceuticalreview
September 27, 2020
CEBINA GmbH has announced further positive results in its collaborative COVID-19 drug repurposing project, demonstrating allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.
CEBINA Identifies Common Antihistamine Nasal Spray as a Potential Anti-COVID-19 Approach americanpharmaceuticalreview
July 20, 2020
CEBINA GmbH has announced positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays.